“The present situation has uncovered some structural weaknesses inside the EU’s medicines source chain plus a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advised that provide chain troubles be resolved within an EU pharmaceutical approach predicted being released by